CAS |
Product Name |
Molecular Formula |
Supplier |
|
1,1'-oxybis(cyclohexane) |
C12H22O |
View |
|
N-(3,4-dimethylphenyl)-2-[(5E)-5-(4-hydroxy-3-nitrobenzylidene)-2,4-dioxo-1,3-thiazolidin-3-yl]acetamide |
C20H17N3O6S |
View |
|
N-(3,4-dimethylphenyl)-2-{(5Z)-5-[3-methoxy-2-(propan-2-yloxy)benzylidene]-2,4-dioxo-1,3-thiazolidin-3-yl}acetamide |
C24H26N2O5S |
View |
|
dipotassium (R*,S*)-tartrate |
C4H7KO6 |
View |
|
7-CHLOROIMIDAZO[1,2-A]PYRIDINE |
C7H5ClN2 |
View |
|
4-Butoxy-3-nitrobenzoic acid |
C11H13NO5 |
View |
|
(2E)-3-(3-chloro-4-methoxyphenyl)-N-(4-chlorophenyl)-2-cyanoprop-2-enamide |
C17H12Cl2N2O2 |
View |
|
1-(4-chlorobenzyl)-1H-perimidine |
C18H13ClN2 |
View |
|
Erythromycin Impurity |
C37H65NO12 |
View |
|
2(1H)-Quinolinethione, 3,4-dihydro- |
C9H9NS |
View |
|
ETHYL 2-[3-CHLORO-5-(TRIFLUOROMETHYL)-2-PYRIDINYL]-3-[(4-FLUOROBENZYL)AMINO]-3-OXOPROPANOATE |
C18H15ClF4N2O3 |
View |
|
1-[4-amino-6-(4-methylanilino)-1,3,5-triazin-2-yl]-3-methoxypropan-2-one |
C14H17N5O2 |
View |
|
(R)-2-AMINO-3-METHYL-1 1-DIPHENYLBUTANE& |
C17H21N |
View |
|
2-(chloromethyl)-1-methylpiperidine |
C7H14ClN |
View |
|
SALOR-INT L242616-1EA |
C22H17ClN4O4S2 |
View |
|
(2R,4aR,4bS,6aS,9aS,9bR,9cR,10aR)-4a,6a-dimethyl-4,4a,4b,5,6,6a,9,9a,9b,9c,10,10a-dodecahydro-2H,3H-spiro[cyclopenta[a]cyclopropa[l]phenanthrene-7,2-furan]-2,5(3H,4H,8H)-dione |
C23H30O3 |
View |
|
3-chloro-1-(4-methoxyphenyl)-4-(3-methylpiperidin-1-yl)pyrrole-2,5-dione |
C17H19ClN2O3 |
View |
|
5-ETHYL-4-METHYL-THIOPHENE-2-CARBOXYLIC ACID |
C8H10O2S |
View |
|
6-Chloropyrimidin-4(3H)-one |
C4H3ClN2O |
View |
|
1H-1,2,3 TRIAZOLE-1-ACETIC ACID |
C4H5N3O2 |
View |
|
3-ethoxy-N-{[4-(naphthalen-2-yl)-1,3-thiazol-2-yl]carbamothioyl}benzamide |
C23H19N3O2S2 |
View |
|
P-AMINOPHENYL-BETA-D-CELLOBIOSIDE |
C18H27NO11 |
View |
|
(R)-(-)-1-(1-NAPHTHYL)ETHYL ISOCYANATE |
C13H11NO |
View |
|
2-Piperazinone, 4-[4-(2-fluoro-10H-phenothiazin-10-yl)butyl]- |
C20H22FN3OS |
View |
|
N,N-([1,1-biphenyl]-4,4-diyl)bis(4-(tert-butyl)benzenesulfonamide) |
C32H36N2O4S2 |
View |
|
N'-[(1Z)-1-(3-bromophenyl)ethylidene]-7-tert-butyl-2,3-dihydro-1,4-benzodioxine-2-carbohydrazide |
C21H23BrN2O3 |
View |
|
2-[[5-[(4-chlorophenyl)methylsulfanyl]-1,3,4-thiadiazol-2-yl]sulfanyl]-N-[(E)-(2-methoxyphenyl)methylideneamino]acetamide |
C19H17ClN4O2S3 |
View |
|
ethyl 2-[[1-(4-ethoxyphenyl)-2,5-dioxopyrrolidin-3-yl]amino]acetate |
C16H20N2O5 |
View |
|
1-[3,5-bis(difluoromethyl)-5-hydroxy-4H-pyrazol-1-yl]-2-(3,4-dichlorophenyl)ethanone |
C13H10Cl2F4N2O2 |
View |
|
Ethanamine, 2-[(6-bromo-2-naphthalenyl)oxy]- |
C12H12BrNO |
View |
|
2,3-Octadiene, 2-methyl- |
C9H16 |
View |
|
fluoromethanol |
CH3FO |
View |
|
2-Pyridinamine,3-methoxy-4-methyl-(9CI) |
C7H10N2O |
View |
|
1-Pentene, 1,1-difluoro- |
C5H8F2 |
View |
|
NITRON |
C20H16N4 |
View |
|
methyl 2-(4-methyl-2-oxochromen-7-yl)oxybutanoate |
C15H16O5 |
View |
|
3-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-1-[4-(hexyloxy)phenyl]pyrrolidine-2,5-dione |
C26H34N2O5 |
View |
|
PERFLUORO-TERT-BUTYL IODIDE |
C4F9I |
View |
|
EC 20 (peptide) |
C29H35N11O11S |
View |
|
1H-1,2,4-Triazole-3-carboxylic acid, 1-(2,3-dichlorophenyl)- |
C9H5Cl2N3O2 |
View |
|
5α-Dihydrocortisol 21-Acetate |
C23H34O6 |
View |
|
DL-7-hydroxy-1,2,3,4-tetrahydro-3-Isoquinolinecarboxylic acid, ethyl ester |
C12H15NO3 |
View |
|
3-benzyl-2-{[2-oxo-2-(1-pyrrolidinyl)ethyl]sulfanyl}-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one |
C23H25N3O2S2 |
View |
|
2-(3-chlorophenoxy)-N-(furan-2-ylmethyl)propanamide |
C14H14ClNO3 |
View |
|
4-phenyl-N,N-dipropyl-2,3-dihydro-1H-cyclopenta[4',5']pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-7-amine |
C24H26N4S |
View |
|
5-(4-chlorophenyl)-1-(2-(diethylamino)ethyl)-4-(4-ethoxy-3-methylbenzoyl)-3-hydroxy-1H-pyrrol-2(5H)-one |
C26 H31 Cl N2 O4 |
View |
|
AC-GLU-ASP(EDANS)-LYS-PRO-ILE-LEU-PHE-PHE-ARG-LEU-GLY-LYS(DABCYL)-GLU-NH2 |
C104H146N24O23S |
View |
|
(-)PPP |
C22H22O8 |
View |
|
7-methyl-2-pyridin-3-yl-1,2,3,5,6,8-hexahydropyrido[2,3]thieno[2,4-d]pyrimidin-4-one |
C15H16N4OS |
View |
|
Propanoic acid, 3-(triphenylphosphoranylidene)-, methyl ester |
C22H21O2P |
View |